DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
BAY-1082439
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
PI3-kinase p110-alpha subunit inhibitor
BAY-1082439
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CS-8080
1
Small molecule
Investigational
Unknown
Unknown
Unknown
LXR-alpha agonist
CS-8080
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CIRMTUZUMAB
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell
Inactive tyrosine-protein kinase transmembrane receptor ROR1 inhibitor
CIRMTUZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
FEH7RQ7B3J
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAS0612
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
p90RSK inhibitor
TAS0612
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C28H36F3N9O
Molecular Weight:
571.65
AlogP:
4.4
PSA:
119.79
HBD:
3.0
HBA:
#RotB:
7.0
Source:
AMG-224
1
Unknown
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
AMG-224
×
Maximum Phase:
1
First Approval:
None
UNII:
Y69B45U0TK
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RODATRISTAT ETHYL
1
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary
Tryptophan 5-hydroxylase 1 inhibitor
RODATRISTAT ETHYL
×
Maximum Phase:
1
First Approval:
None
UNII:
507FY6OL37
Molecule Type:
Small molecule
Molecular Formula:
C29H31ClF3N5O3
Molecular Weight:
590.05
AlogP:
5.57
PSA:
102.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
BMS-962476
1
Unknown
Investigational
Unknown
Unknown
Atherosclerosis
Unknown
BMS-962476
×
Maximum Phase:
1
First Approval:
None
UNII:
OSI903EJOV
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MAFOSFAMIDE
1
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Leukemia; Lymphoma; Meningeal Neoplasms
Unknown
MAFOSFAMIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
5970HH9923
Molecule Type:
Small molecule
Molecular Formula:
C9H19Cl2N2O5PS2
Molecular Weight:
401.27
AlogP:
1.83
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
9.0
Source:
PROFILNINE SD
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PROFILNINE SD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-945237
1
Small molecule
Investigational
Unknown
Unknown
Infections
Unknown
GSK-945237
×
Maximum Phase:
1
First Approval:
None
UNII:
U9T63BZ3AS
Molecule Type:
Small molecule
Molecular Formula:
C24H26FN5O3
Molecular Weight:
451.5
AlogP:
2.05
PSA:
81.51
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ORIC-101
1
Unknown
Investigational
Unknown
Unknown
Neoplasms; Prostatic Neoplasms
Unknown
ORIC-101
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RXDX-105
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RXDX-105
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GDC-0152
1
Protein
Investigational
Unknown
Unknown
Neoplasms
Unknown
GDC-0152
×
Maximum Phase:
1
First Approval:
None
UNII:
4KW1M48SHS
Molecule Type:
Protein
Molecular Formula:
C25H34N6O3S
Molecular Weight:
498.65
AlogP:
2.81
PSA:
116.32
HBD:
3.0
HBA:
#RotB:
8.0
Source:
VLX-1005
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VLX-1005
×
Maximum Phase:
1
First Approval:
None
UNII:
JKU4XCC48Y
Molecule Type:
Small molecule
Molecular Formula:
C21H19N3O4S2
Molecular Weight:
441.53
AlogP:
4.42
PSA:
100.55
HBD:
3.0
HBA:
#RotB:
7.0
Source:
BRICICLIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
G1/S-specific cyclin D1 inhibitor
BRICICLIB
×
Maximum Phase:
1
First Approval:
None
UNII:
WG93X96336
Molecule Type:
Small molecule
Molecular Formula:
C19H23O10PS
Molecular Weight:
474.42
AlogP:
2.78
PSA:
137.82
HBD:
2.0
HBA:
#RotB:
10.0
Source:
TB
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
TB
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
D6-25-HYDROXYVITAMIN D3
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
D6-25-HYDROXYVITAMIN D3
×
Maximum Phase:
1
First Approval:
None
UNII:
378HY809HV
Molecule Type:
Small molecule
Molecular Formula:
C27H44O2
Molecular Weight:
406.68
AlogP:
6.73
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
6.0
Source:
TRANSTORINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TRANSTORINE
×
Maximum Phase:
1
First Approval:
None
UNII:
H030S2S85J
Molecule Type:
Small molecule
Molecular Formula:
C10H7NO3
Molecular Weight:
189.17
AlogP:
1.23
PSA:
70.16
HBD:
2.0
HBA:
#RotB:
1.0
Source:
NG-NITRO-L-ARGININE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NG-NITRO-L-ARGININE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-791826
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-791826
×
Maximum Phase:
1
First Approval:
None
UNII:
60BN6CDL0K
Molecule Type:
Small molecule
Molecular Formula:
C28H26FN5O3S
Molecular Weight:
531.61
AlogP:
5.73
PSA:
97.31
HBD:
1.0
HBA:
#RotB:
6.0
Source:
TRODUSQUEMINE
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
TRODUSQUEMINE
×
Maximum Phase:
1
First Approval:
None
UNII:
KKC12PIF16
Molecule Type:
Small molecule
Molecular Formula:
C37H72N4O5S
Molecular Weight:
685.07
AlogP:
5.53
PSA:
145.94
HBD:
6.0
HBA:
#RotB:
20.0
Source:
.ALPHA.-PYRROLIDINONONANOPHENONE
1
Small molecule
Investigational
Unknown
Unknown
Melanoma
Unknown
.ALPHA.-PYRROLIDINONONANOPHENONE
×
Maximum Phase:
1
First Approval:
None
UNII:
S3FKL8RY1D
Molecule Type:
Small molecule
Molecular Formula:
C19H29NO
Molecular Weight:
287.45
AlogP:
4.69
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
9.0
Source:
LETRAZURIL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LETRAZURIL
×
Maximum Phase:
1
First Approval:
None
UNII:
U8736VCB22
Molecule Type:
Small molecule
Molecular Formula:
C17H9Cl2FN4O2
Molecular Weight:
391.19
AlogP:
3.02
PSA:
91.54
HBD:
1.0
HBA:
#RotB:
3.0
Source:
GSK2981278
1
Small molecule
Investigational
Unknown
Unknown
Psoriasis
Unknown
GSK2981278
×
Maximum Phase:
1
First Approval:
None
UNII:
L49V5G013I
Molecule Type:
Small molecule
Molecular Formula:
C25H35NO5S
Molecular Weight:
461.62
AlogP:
4.4
PSA:
76.07
HBD:
1.0
HBA:
#RotB:
10.0
Source:
ANSOFAXINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ANSOFAXINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BEXMARILIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
BEXMARILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-04418948
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-04418948
×
Maximum Phase:
1
First Approval:
None
UNII:
I7Z38E70VF
Molecule Type:
Small molecule
Molecular Formula:
C23H20FNO5
Molecular Weight:
409.41
AlogP:
3.59
PSA:
76.07
HBD:
1.0
HBA:
#RotB:
6.0
Source:
AZD5312
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AZD5312
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PLB1003
1
Unknown
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
ALK tyrosine kinase receptor inhibitor
PLB1003
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IMC-EB10
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid
Tyrosine-protein kinase receptor FLT3 inhibitor
IMC-EB10
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATIPAMEZOLE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ATIPAMEZOLE
×
Maximum Phase:
1
First Approval:
None
UNII:
03N9U5JAF6
Molecule Type:
Small molecule
Molecular Formula:
C14H16N2
Molecular Weight:
212.3
AlogP:
2.86
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PFK-158
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
PFK-158
×
Maximum Phase:
1
First Approval:
None
UNII:
2HOK1JQ203
Molecule Type:
Small molecule
Molecular Formula:
C18H11F3N2O
Molecular Weight:
328.29
AlogP:
4.54
PSA:
42.85
HBD:
0.0
HBA:
#RotB:
3.0
Source:
LODAPOLIMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Melanoma; Neoplasms; Pancreatic Neoplasms
Unknown
LODAPOLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
NR4MAD6PPB
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
G1T28-1
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cyclin-dependent kinase 4 inhibitor
G1T28-1
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SAFINGOL
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SAFINGOL
×
Maximum Phase:
1
First Approval:
None
UNII:
OWA98U788S
Molecule Type:
Small molecule
Molecular Formula:
C18H39NO2
Molecular Weight:
301.52
AlogP:
4.15
PSA:
66.48
HBD:
3.0
HBA:
#RotB:
16.0
Source:
1
2
…
100
101
102
103
104
105
106
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA